Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million
https://techcrunch.com/2020/05/11/biotherapeutics-startup-hummingbird-bioscience-brings-its-total-series-b-funding-to-25-million/
Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the round’s total to $25 million.
The extension was led by SK Holdings, and included participation from returning investors including Heritas Capital and SEEDS Capital, the investment arm of Enterprise Singapore, a government agency that supports small- to medium-sized businesses.
Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million
May 11, 2020, 8:17am UTC
https://techcrunch.com/2020/05/11/biotherapeutics-startup-hummingbird-bioscience-brings-its-total-series-b-funding-to-25-million/
> Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the round’s total to $25 million.
> The extension was led by SK Holdings, and included participation from returning investors including Heritas Capital and SEEDS Capital, the investment arm of Enterprise Singapore, a government agency that supports small- to medium-sized businesses.